2025/2729(DEA)
Inclusion of the drug precursors 4-piperidone and 1-boc-4-piperidone in the list of scheduled substances
Basic information
2025/2729(DEA)
DEA - Delegated acts procedure
Amending Regulation 2004/0273 2002/0217(COD)
Subject
7.30.30.04 Action to combat drugs and drug-trafficking
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 21/05/2025 | Non-legislative basic document published | C(2025)03079 | |
| 21/05/2025 | Initial period for examining delegated act 2 month(s) | ||
| 18/06/2025 | Committee referral announced in Parliament | ||
| 30/07/2025 | Delegated act not objected by Parliament |
Technical information
| Procedure reference | 2025/2729(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Amendments and repeals | Amending Regulation 2004/0273 2002/0217(COD) |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
LIBE/10/02908
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2025)03079 21/05/2025